NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $726,748 | -25.8% | 101,023 | -22.1% | 0.01% | -23.1% |
| Q2 2023 | $979,026 | +11.4% | 129,617 | +3.5% | 0.01% | +18.2% |
| Q1 2023 | $878,700 | -23.6% | 125,283 | +11.2% | 0.01% | -35.3% |
| Q4 2022 | $1,150,861 | -43.0% | 112,615 | +5.6% | 0.02% | -46.9% |
| Q3 2022 | $2,019,000 | -43.1% | 106,601 | +55.9% | 0.03% | -39.6% |
| Q2 2022 | $3,547,000 | -9.0% | 68,368 | +30.1% | 0.05% | 0.0% |
| Q1 2022 | $3,899,000 | +220.1% | 52,537 | +553.0% | 0.05% | +231.2% |
| Q4 2021 | $1,218,000 | -27.0% | 8,046 | -0.2% | 0.02% | -38.5% |
| Q3 2021 | $1,668,000 | +172.5% | 8,066 | +181.9% | 0.03% | +136.4% |
| Q2 2021 | $612,000 | – | 2,861 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |